Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) ROA %: 7.06% (As of Mar. 2026) — 35% Below Median


SHSE:605033 Shaanxi Meibang Pharmaceutical Group Co Ltd SHSE:605033
81 GF Score
Price ¥17.37
GF Value ¥22.13
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Shaanxi Meibang Pharmaceutical Group Co ROA %?

Shaanxi Meibang Pharmaceutical Group Co SHSE:605033 +1.82% 81 ROA % is 7.06% as of Mar. 2026, which is 35% below its 10-year median of 10.83. GuruFocus rates SHSE:605033 with a GF Score™ of 81/100 and a GF Value™ of ¥22.13 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 259 Agriculture companies, Shaanxi Meibang Pharmaceutical Group Co ranks worse than 53.28% on this metric.

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Shaanxi Meibang Pharmaceutical Group Co's annualized Net Income for the quarter that ended in Mar. 2026 was ¥142.5 Mil. Shaanxi Meibang Pharmaceutical Group Co's average Total Assets over the quarter that ended in Mar. 2026 was ¥2,019.1 Mil. Therefore, Shaanxi Meibang Pharmaceutical Group Co's annualized ROA % for the quarter that ended in Mar. 2026 was 7.06%.

The historical rank and industry rank for Shaanxi Meibang Pharmaceutical Group Co's ROA % or its related term are showing as below:

SHSE:605033' s ROA % Range Over the Past 10 Years
Min: 2.07   Med: 10.83   Max: 12.18
Current: 2.85

During the past 9 years, Shaanxi Meibang Pharmaceutical Group Co's highest ROA % was 12.18%. The lowest was 2.07%. And the median was 10.83%.

SHSE:605033's ROA % is ranked worse than
53.28% of 259 companies
in the Agriculture industry
Industry Median: 3.27 vs SHSE:605033: 2.85

Shaanxi Meibang Pharmaceutical Group Co  (SHSE:605033) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Mar. 2026 )
=Net Income/Total Assets
=142.48/2019.0595
=(Net Income / Revenue)*(Revenue / Total Assets)
=(142.48 / 1345.352)*(1345.352 / 2019.0595)
=Net Margin %*Asset Turnover
=10.59 %*0.6663
=7.06 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Shaanxi Meibang Pharmaceutical Group Co ROA % Related Terms


Shaanxi Meibang Pharmaceutical Group Co ROA % Historical Data

* Premium members only.

The historical data trend for Shaanxi Meibang Pharmaceutical Group Co's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shaanxi Meibang Pharmaceutical Group Co ROA % Chart

Shaanxi Meibang Pharmaceutical Group Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROA %
Get a 7-Day Free Trial Premium Member Only 11.18 9.60 3.54 2.07 2.48

Shaanxi Meibang Pharmaceutical Group Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.49 1.38 0.01 2.51 7.06

SHSE:605033 vs CTVA, CF, MOS: ROA % Comparison

For the Agricultural Inputs subindustry, Shaanxi Meibang Pharmaceutical Group Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shaanxi Meibang Pharmaceutical Group Co ROA % vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, Shaanxi Meibang Pharmaceutical Group Co's ROA % distribution charts can be found below:

* The bar in red indicates where Shaanxi Meibang Pharmaceutical Group Co's ROA % falls into.


SHSE:605033
81GF Score
Shaanxi Meibang Pharmaceutical Group Co Ltd SHSE:605033
ROA % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shaanxi Meibang Pharmaceutical Group Co ROA % Calculation

Shaanxi Meibang Pharmaceutical Group Co's annualized ROA % for the fiscal year that ended in Dec. 2025 is calculated as:

ROA %=Net Income (A: Dec. 2025 )/( (Total Assets (A: Dec. 2024 )+Total Assets (A: Dec. 2025 ))/ count )
=48.665/( (1862.032+2068.131)/ 2 )
=48.665/1965.0815
=2.48 %

Shaanxi Meibang Pharmaceutical Group Co's annualized ROA % for the quarter that ended in Mar. 2026 is calculated as:

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=142.48/( (2068.131+1969.988)/ 2 )
=142.48/2019.0595
=7.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2026) net income data. ROA % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROA % →
What does a ROA % of 7.06% mean?
Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) has a ROA % of 7.06% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Shaanxi Meibang Pharmaceutical Group Co and its competitors. This is 35% below median its historical median of 10.83. Over the past decade, Shaanxi Meibang Pharmaceutical Group Co's ROA % has ranged from 2.07 to 12.18. According to the industry distribution chart, Shaanxi Meibang Pharmaceutical Group Co ranks #138 out of 259 companies in the Agriculture industry, placing it in the top 53.3%.
Is Shaanxi Meibang Pharmaceutical Group Co's ROA % too high?
Shaanxi Meibang Pharmaceutical Group Co's current ROA % of 7.06% is 35% below median its 10-year median of 10.83. Over the past 10 years, this metric has ranged from a low of 2.07 to a high of 12.18. The Agriculture industry median ROA % is 3.27. Shaanxi Meibang Pharmaceutical Group Co's value of 7.06% is 115.9% above this industry median. Based on the distribution chart, Shaanxi Meibang Pharmaceutical Group Co ranks #138 out of 259 companies in the Agriculture industry, which is below the industry midpoint. Overall, Shaanxi Meibang Pharmaceutical Group Co has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shaanxi Meibang Pharmaceutical Group Co's ROA % compare to CTVA and CF?
According to the Agriculture industry distribution chart, Shaanxi Meibang Pharmaceutical Group Co ranks #138 out of 259 companies for ROA %. This places Shaanxi Meibang Pharmaceutical Group Co in the lower half of its industry. The industry median ROA % is 3.27. Shaanxi Meibang Pharmaceutical Group Co's value of 7.06% is 115.9% above this benchmark. Historically, Shaanxi Meibang Pharmaceutical Group Co's own ROA % has ranged from 2.07 to 12.18 over the past decade. While the company's 10-year median is 10.83 vs. the industry median of 3.27, Shaanxi Meibang Pharmaceutical Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for an Agriculture company?
The median ROA % among Agriculture companies is 3.27, based on 259 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shaanxi Meibang Pharmaceutical Group Co's current ROA % of 7.06% is 115.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Shaanxi Meibang Pharmaceutical Group Co and its competitors. For the Agriculture industry, the median ROA % is 3.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shaanxi Meibang Pharmaceutical Group Co's current ROA % is 7.06%, which is 35% below median its own 10-year median of 10.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shaanxi Meibang Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥22.13, compared to a current price of ¥17.37 — trading 21.5% below its estimated fair value. The current ROA % is 7.06%, which is 35% below median its 10-year median of 10.83 and 115.9% above the Agriculture industry median of 3.27. Shaanxi Meibang Pharmaceutical Group Co's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033), the current ROA % is 7.06% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) Overvalued in 2026?

Based on GuruFocus' analysis, Shaanxi Meibang Pharmaceutical Group Co stock appears to be undervalued. The current stock price of ¥17.37 is trading 21.5% below its estimated GF Value™ of ¥22.13. GuruFocus considers Shaanxi Meibang Pharmaceutical Group Co to be Modestly Undervalued.

Key valuation signals for SHSE:605033:

  • ROA %: 7.06% (35% below median its 10-year median of 10.83)
  • GF Value™: ¥22.13 vs. price of ¥17.37 (21.5% below fair value)
  • GF Score™: 81/100 with 3 warning signs
  • Industry Position: 115.9% above the Agriculture median (#138 of 259)

No single metric tells the full story. See the SHSE:605033 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shaanxi Meibang Pharmaceutical Group Co Business Description

Address High-tech Industrial Development Zone, Pucheng County, Shaanxi Province, Weinan, CHN, 715500
Shaanxi Meibang Pharmaceutical Group Co Ltd is engaged in the research and development, production and sales of pesticide formulations.
81GF Score

Get the complete analysis for SHSE:605033

ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥17.37
Price
¥22.13
GF Value